Self-assembly supramolecular drug delivery system for combination of photodynamic therapy and chemotherapy

References

• Droge, W. 2002. Free radicals in the physiological control of cell function. Physiological reviews, 82, 47–95.
   PubMed Web of Science ®Google Scholar
• Eftekhari, R.B., et al., 2019. Co-delivery nanosystems for cancer treatment: a review. Pharmaceutical nanotechnology, 7 (2), 90–112.
   PubMedGoogle Scholar
• Gaio, E., et al., 2020. CD44 targeting mediated by polymeric nanoparticles and combination of chlorine TPCS(2a)-PDT and docetaxel-chemotherapy for efficient killing of breast differentiated and stem cancer cells in vitro. Cancers (cancers), 12 (2), 278.
   Web of Science ®Google Scholar
• Guo, X., et al., 2017. Synergistic antiproliferative effect of chemo-phototherapy: Synthesis and photodynamic activity evaluation of novel Chlorin e6-artesunate conjugates as antiproliferative agents. Bioorganic and medicinal chemistry letters, 27 (19), 4548–4551.
   PubMed Web of Science ®Google Scholar
• Henderson, B.W., and Fingar, V.H., 1987. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer res, 47, 3110–3114.
   PubMed Web of Science ®Google Scholar
• Homayun, B., Lin, X., and Choi, H.J., 2019. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics, 11 (3), 129.
   PubMed Web of Science ®Google Scholar
• Jalde, S.S., et al., 2018. Synthesis of novel Chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma. European journal of medicinal chemistry, 147, 66–76.
   PubMed Web of Science ®Google Scholar
• Jia, J.B., et al., 2011. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Investigational new drugs, 29 (5), 861–872.
   PubMed Web of Science ®Google Scholar
• Jian, X., et al., 2012. Subcellular location of antitumor tripeptide-tyroserleutide in human hepatocellular carcinoma cells. Experimental and therapeutic medicine, 3 (2), 195–199.
   PubMed Web of Science ®Google Scholar
• Justus, C.R., Dong, L., and Yang, L.V., 2013. Acidic tumor microenvironment and pH-sensing G protein-coupled receptors. Frontiers in physiology, 4, 354
   PubMed Web of Science ®Google Scholar
• Lee, H., et al., 2018. Combination of chemotherapy and photodynamic therapy for cancer treatment with sonoporation effects. Journal of control release, 283, 190–199.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2019. Light-activated drug release from prodrug nanoassemblies by structure destruction. Chemical communications (Cambridge, England)), 55 (87), 13128–13131.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2020. Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer. Journal of controlled release: official journal of the controlled release society, 321, 589–601.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2018. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis. Journal of controlled release: official journal of the controlled release society, 278, 127–139.
   PubMed Web of Science ®Google Scholar
• Qin, S.Y., et al., 2017. Drug self-delivery systems for cancer therapy. Biomaterials, 112, 234–247.
   PubMed Web of Science ®Google Scholar
• Shi, L., et al., 2020. Hybrid nanospheres to overcome hypoxia and intrinsic oxidative resistance for enhanced photodynamic therapy. ACS nano, 14 (2), 2183–2190.
   PubMed Web of Science ®Google Scholar
• Sounni, N.E., and Noel, A., 2013. Targeting the tumor microenvironment for cancer therapy. Clinical chemistry, 59 (1), 85–93.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2020. Mixed micelles of TPGS and Soluplus(®) for co-delivery of paclitaxel and fenretinide: in vitro and in vivo anticancer study. Pharmaceutical development and technology, 25（7), 865–873.
   Web of Science ®Google Scholar
• Yang, D., et al., 2018. The π-π stacking-guided supramolecular self-assembly of nanomedicine for effective delivery of antineoplastic therapies. Nanomedicine (London, England)), 13 (24), 3159–3177.
   PubMed Web of Science ®Google Scholar
• Yang, M.Y., et al., 2019. Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy. International journal of pharmaceutics, 570, 118663.
   PubMed Web of Science ®Google Scholar
• Yao, Z., et al., 2006. The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma. Peptides, 27 (6), 1167–1172.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2020a. Protein-drug conjugate programmed by pH-reversible linker for tumor hypoxia relief and enhanced cancer combination therapy. International journal of pharmaceutics, 582, 119321.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2019. Co-delivery of rose bengal and doxorubicin nanoparticles for combination photodynamic and chemo-therapy. Journal of biomedical nanotechnology, 15 (1), 184–195.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2020b. Recent advances of smart acid-responsive gold nanoparticles in tumor therapy. Wiley interdisciplinary reviews: nanomedicine and nanobiotechnology., 12（4), e1619.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2017. The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells. OncoTargets and therapy, 10, 5653–5666.
   PubMed Web of Science ®Google Scholar
• Zhou, G., et al., 2016. Optimal ROS signaling is critical for nuclear reprogramming. Cell reports, 15 (5), 919–925.
   PubMed Web of Science ®Google Scholar
• Zhu, T., et al., 2019. Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics, 9 (11), 3293–3307.
   PubMed Web of Science ®Google Scholar
• Zou, Z., et al., 2017. Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis: an international journal on programmed cell death, 22 (11), 1321–1335.
   PubMed Web of Science ®Google Scholar
• Zununi Vahed, S., et al., 2017. Liposome-based drug co-delivery systems in cancer cells. Material science and engineering C Material biology application, 71, 1327–1341.
   PubMed Web of Science ®Google Scholar